GlobeNewswire
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit
📊
AI Sentiment
Positive
6/10
- Home
- FGEN
FGEN
FibroGen Inc
as of 12-05-2025 12:28pm EST
$8.41
$0.01
-0.12%
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
Chart Type:
Time Range:
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 35.6M | IPO Year: | 2014 |
| Target Price: | $146.50 | AVG Volume (30 days): | 40.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 53.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.85 - $21.94 | Next Earning Date: | 11-10-2025 |
| Revenue: | $8,298,000 | Revenue Growth: | -36.71% |
| Revenue Growth (this year): | -76.93% | Revenue Growth (next year): | -8.66% |
AI-Powered FGEN Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 15 hours ago
AI Recommendation
hold
Model Accuracy: 80.54%
80.54%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of FibroGen Inc (FGEN)
Wettig Thane
Buy
CEO
FGEN Nov 17, 2025
Avg Cost/Share
$9.10
Shares
2,700
Total Value
$24,569.73
Owned After
24,939
SEC Form 4
Wettig Thane
Buy
CEO
FGEN Nov 13, 2025
Avg Cost/Share
$9.18
Shares
1,000
Total Value
$9,180.00
Owned After
24,939
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Wettig Thane | FGEN | CEO | Nov 17, 2025 | Buy | $9.10 | 2,700 | $24,569.73 | 24,939 | |
| Wettig Thane | FGEN | CEO | Nov 13, 2025 | Buy | $9.18 | 1,000 | $9,180.00 | 24,939 |
Latest FibroGen Inc News
FGEN Breaking Stock News: Dive into FGEN Ticker-Specific Updates for Smart Investing
Compare FGEN vs Leading Stocks
See how FGEN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "FGEN FibroGen Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.